Dihydroergotamine | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Dihydroergotamine
US Patents

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Dihydroergotamine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

8 API Suppliers, 7 USDMF, 3 CEP/COS, 9 NDC API, 4 Listed Suppliers, $ API Reference Price

8 API Suppliers
7 USDMF
3 CEP/COS
9 NDC API
4 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

31 Drugs in Development

31 Drugs in Development

FINISHED DOSAGE FORMULATIONS

24 FDF Dossiers, 16 FDA Orange Book, 4 Europe, 2 Canada, 2 Listed Dossiers

24 FDF Dossiers
16 FDA Orange Book
4 Europe
2 Canada
2 Listed Dossiers

RELATED EXCIPIENT COMPANIES

2 Actylis, 1 Kerry, 1 Pluviaendo

2 Actylis
1 Kerry
1 Pluviaendo

EXCIPIENTS BY APPLICATIONS

3 Parenteral, 1 Film Formers & Plasticizers, 1 Coating Systems & Additives, 1 Topical, 1 Controlled & Modified Release

3 Parenteral
1 Film Formers & Plasticizers
1 Coating Systems & Additives
1 Topical
1 Controlled & Modified Release

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 19 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
19 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 3 Finished Drug Prices, 4 Annual Reports

1 US Medicaid Prescriptions
3 Finished Drug Prices
4 Annual Reports

MARKET PLACE

4 APIs, 1 FDF Dossiers

4 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents, 1 US Exclusivities, 1 Health Canada Patents

6 US Patents
1 US Exclusivities
1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 1 JP, 1 Others

3 EDQM
1 USP
1 JP
1 Others

$ API Ref.Price (USD/KG) : 196,288 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 6IMPEL PHARMS

filter Patent Number Reset all filters

6 All

01 19550036

02 19919117

03 110507295

04 110940278

05 111185497

06 111266799

filter API Patent Reset all filters

6 All

01 6Blank

filter FDF Patent Reset all filters

6 All

01 5Y

02 1Blank

filter Expiration Date Reset all filters

6 All

01 12032-09-05

02 12032-12-25

03 12033-01-23

04 12033-03-17

05 12036-11-05

06 12039-01-04

Product Main Page

01

IMPEL PHARMS

DIHYDROERGOTAMINE MESYLATE

2024 ACI Convention

Not Confirmed

IMPEL PHARMS

Country

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-01-04

DIHYDROERGOTAMINE MESYLATE

US Patent Number : 11185497

Drug Substance Claim :

Drug Product Claim :

Application Number : 213436

Patent Use Code : U-3218

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-01-04

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

IMPEL PHARMS

DIHYDROERGOTAMINE MESYLATE

2024 ACI Convention

Not Confirmed

IMPEL PHARMS

Country

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-03-17

DIHYDROERGOTAMINE MESYLATE

US Patent Number : 9919117

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213436

Patent Use Code : U-3218

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-03-17

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

IMPEL PHARMS

DIHYDROERGOTAMINE MESYLATE

2024 ACI Convention

Not Confirmed

IMPEL PHARMS

Country

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-01-23

DIHYDROERGOTAMINE MESYLATE

US Patent Number : 10940278

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213436

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-01-23

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

IMPEL PHARMS

DIHYDROERGOTAMINE MESYLATE

2024 ACI Convention

Not Confirmed

IMPEL PHARMS

Country

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-09-05

DIHYDROERGOTAMINE MESYLATE

US Patent Number : 9550036

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213436

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-09-05

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

IMPEL PHARMS

DIHYDROERGOTAMINE MESYLATE

2024 ACI Convention

Not Confirmed

IMPEL PHARMS

Country

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-12-25

DIHYDROERGOTAMINE MESYLATE

US Patent Number : 10507295

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213436

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-12-25

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

IMPEL PHARMS

DIHYDROERGOTAMINE MESYLATE

2024 ACI Convention

Not Confirmed

IMPEL PHARMS

Country

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2036-11-05

DIHYDROERGOTAMINE MESYLATE

US Patent Number : 11266799

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213436

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-11-05

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?